Millstone Announces Launch of Millstone Testing Services
Millstone Medical Outsourcing is excited to announce the launch of Millstone Testing Services, its new division offering a comprehensive range of product, packaging, and environmental testing for the medical device and pharmaceutical industries.
On November 14, Millstone acquired two leading testing organizations, MycoScience and Ethide Laboratories. This exciting acquisition brings together 90 years of experience in regulatory testing services for the medical device and pharmaceutical industries. With Millstone Testing Services, customers now have the option of having Millstone complete a broad range of adjacent testing in-house, with better controls around product testing, reduced lead times for in-process testing within production, and accelerated time to market. The launch of Millstone Testing Services also enhances Millstone’s Tier 1 approach to expert sourcing and support for medical device manufacturers.
Through Millstone Testing Services, our full range of capabilities now include:
- Bioburden
- Sterility
- Bacterial Endotoxin
- Microbial Identifications
- Particulate Analysis
- Cytotoxicity Testing
- Water Analysis
- Sterilization/Cleaning Validations of Reusable Devices
- Gamma Sterilization Validations
- EtO Residual Testing
- Preservative Efficacy Testing
- Environmental Monitoring
- Dye Penetration Testing
- Bubble Emission Testing
- Peel Strength Testing
- Accelerated Aging
“With these acquisitions and the longstanding expertise they bring to the Millstone family of companies, we can offer our customers enhanced support and a broader range of testing services, with a single expert point of contact,” Millstone Medical Outsourcing CEO Karl Neuberger said. “The more advanced and thorough post-manufacturing and aftermarket services we can offer our customers, the more we can support them in creating and accelerating products that change patients’ lives. This acquisition brings together two highly experienced and successful companies aligned on commitment to quality, expertise, and outstanding customer service into a single entity within Millstone.”
Both Ethide Laboratories and MycoScience are ISO 13485:2016 certified and GLP compliant contract testing organizations with a rigorous approach to quality that will uphold Millstone’s commitment to operating under the highest quality standards.
Leadership from Ethide Laboratories and MycoScience have joined Millstone Testing Services. Regarding the acquisition, Ethide Laboratories and MycoScience CEO Sarath Koruprolu said, “For decades our companies have supported the medical device and pharmaceutical industries with expert guidance and accelerated turnaround times so our customers can focus on bringing products to market faster. We are thrilled to join forces with Millstone and to bring our expertise together with theirs to help our customers deliver life-changing and lifesaving products.”
Millstone General Manager Tom Williams noted robust growth in demand by manufacturers for Tier 1 support. “OEMs are continually looking to be more strategic, and to find new opportunities to create tighter integration in the supply chain, especially over the last three years. Millstone has been able to rise to the challenge of helping manufacturers succeed with a comprehensive approach to expert sourcing and support through Tier 1. The launch of Millstone Testing Services will help us continue to build capabilities to serve this growing customer base.”
“Since our founding in 2000, Millstone has been strategic about expansions in services and footprint that serve our customers,” Karl Neuberger added. “Establishing Millstone Testing Services to bring this expertise in-house furthers our growth by broadening the services we offer for a single device. It’s a win-win for us all.”
